Skip to main content
. Author manuscript; available in PMC: 2017 Jul 1.
Published in final edited form as: Mol Carcinog. 2015 Jul 8;55(7):1187–1195. doi: 10.1002/mc.22361

Table III.

Tumorigenicity of azoxymethane (AOM) followed by dextran sulfate sodium (DSS) in WT and immune compromised C67Bl/6 mice

Treatment Mouse Strain # of mice Incidence Adenomas Carcinomas Multiplicity
10 mg/kg AOM + 2% DSS Foxn1/Ja 20 14 6 16 22
Foxn1nu/Jb 20 n/ac n/a n/a n/a
10 mg/kg AOM + 1% DSS Foxn1/Ja 20 0 - - -
Foxn1nu/Jb 20 0 - - -
15 mg/kg AOM + 1.5% DSS Foxn1/Ja 14 12 11d 22e,j 32
Foxn1nu/Jb 12 11 19d 7e 26
15 mg/kg AOM + 1.5% DSS WT 12 7f,g 7 6j 13h,i
TCRβ−/− 10 1f,k 1l 0 1h,m
TCRδ−/− 9 3 3 0 3
TCRβ−/−δ−/− 9 1g 1 0 1i
10 mg/kg AOM + 2% DSS WT 12 10 11 10 21
TCRβ−/− 12 11k 10l 12 22m
a

heterozygote B6.

b

homozygote (athymic) B6.

c

animals died or had to be sacrificed immediately after exposure to DSS.

d

p-value: 0.020 (T-test).

e

p-value: 0.046 (T-test).

f

p-value: 0.026 (Fisher’s exact test).

g

p-value: 0.038 (Fisher’s exact test).

h

p-value: 0.024 (T-test).

i

p-value: 0.025 (T-test).

j

p-value: 0.027 (T-test).

k

p-value: 0.015 (Fisher’s exact test).

l

p-value: 0.012 (T-test).

m

p-value 9.250e−05(T-test).